Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Join CGT Catapult and the University of Oxford for their virtual seminar on the key considerations for commercialisation and translation of cell and gene therapy research. There is also the opportunity to sign up for a one-to-one session with CGT Catapult experts to receive tailored feedback on your project idea or proposal.

This image is advertising a virtual seminar, CGT Catapult Advanced Therapies Seminar with University of Oxford, being held on Wednesday 21st October 2020.

Sessions include:

  • Overcoming barriers to scale-up manufacturing
  • Addressing current and future pre-clinical ATMP development and regulatory needs
  • Considering your intellectual property and commercial needs

 

Speakers:

  • Dr Sam Goldsmith, University Liaison Manager, CGT Catapult
  • Dr Jonathan Appleby, CSO, CGT Catapult
  • Professor Robert MacLaren, Professor of Ophthalmology, University of Oxford
  • Dr Mustafa Munye, Lead Scientist, CGT Catapult
  • Dr Valeria Iansante, Non-Clinical Manager, CGT Catapult
  • Dr Matthew Garner, Head of IP, CGT Catapult

 

You can also sign up for a one-to-one session with CGT Catapult experts to receive tailored feedback on your project idea or proposal. These sessions will be scheduled after the seminar. 

 

For more information and to register, click here.